256 related articles for article (PubMed ID: 36645706)
1. Reporting, Monitoring, and Handling of Adverse Drug Reactions in Australia: Scoping Review.
Fossouo Tagne J; Yakob RA; Dang TH; Mcdonald R; Wickramasinghe N
JMIR Public Health Surveill; 2023 Jan; 9():e40080. PubMed ID: 36645706
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
[TBL] [Abstract][Full Text] [Related]
3. Community pharmacists' knowledge and perspectives of reporting adverse drug reactions in Australia: a cross-sectional survey.
Li R; Curtain C; Bereznicki L; Zaidi STR
Int J Clin Pharm; 2018 Aug; 40(4):878-889. PubMed ID: 30097819
[TBL] [Abstract][Full Text] [Related]
4. Exploring the factors and barriers of healthcare professionals in tertiary care hospitals toward pharmacovigilance: a multicenter study from Khyber Pakhtunkhwa, Pakistan.
Sharif MJH; Farrukh MJ; Khan FU; Khan Q; Ahmed SS; Kousar R; Ahmad T; Abid SMA; Ashfaq M; Khan SA
Curr Med Res Opin; 2022 Apr; 38(4):595-605. PubMed ID: 35166143
[TBL] [Abstract][Full Text] [Related]
5. Current Scenario and Future Prospects of Adverse Drug Reactions (ADRs) Monitoring and Reporting Mechanisms in the Rural Areas of India.
Shukla S; Sharma P; Gupta P; Pandey S; Agrawal R; Rathour D; Kumar Kewat D; Singh R; Kumar Thakur S; Paliwal R; Sulakhiya K
Curr Drug Saf; 2024; 19(2):172-190. PubMed ID: 37132145
[TBL] [Abstract][Full Text] [Related]
6. Knowledge, attitudes and practice regarding pharmacovigilance and adverse drug reaction reporting among physicians and pharmacists in Egypt: a step toward personalized medicine implementation.
Aziz AA; Rogers S; Hassanien O; Shalaby L; Nagy M
Per Med; 2022 Nov; 19(6):495-507. PubMed ID: 36239598
[TBL] [Abstract][Full Text] [Related]
7. Barriers and Facilitators Influencing Real-time and Digital-Based Reporting of Adverse Drug Reactions by Community Pharmacists: Qualitative Study Using the Task-Technology Fit Framework.
Fossouo Tagne J; Yakob RA; Mcdonald R; Wickramasinghe N
Interact J Med Res; 2022 Oct; 11(2):e40597. PubMed ID: 36222800
[TBL] [Abstract][Full Text] [Related]
8. Knowledge, attitudes and perspective on adverse drug reaction reporting in a public sector hospital in South Africa: baseline analysis.
Terblanche A; Meyer JC; Godman B; Summers RS
Hosp Pract (1995); 2017 Dec; 45(5):238-245. PubMed ID: 28914115
[TBL] [Abstract][Full Text] [Related]
9. A new paradigm in adverse drug reaction reporting: consolidating the evidence for an intervention to improve reporting.
Li R; Curtis K; Zaidi ST; Van C; Castelino R
Expert Opin Drug Saf; 2022 Sep; 21(9):1193-1204. PubMed ID: 36031811
[TBL] [Abstract][Full Text] [Related]
10. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
11. A comprehensive intervention for adverse drug reactions identification and reporting in a Pediatric Emergency Department.
Morales Ríos O; Jasso Gutiérrez L; Talavera JO; Téllez-Rojo MM; Olivar López V; Garduño Espinosa J; Muñoz Hernández O
Int J Clin Pharm; 2016 Feb; 38(1):80-7. PubMed ID: 26499501
[TBL] [Abstract][Full Text] [Related]
12. Prevalence, characteristics, and reporting of adverse drug reactions in an Australian hospital: a retrospective review of hospital admissions due to adverse drug reactions.
Li R; Curtis K; Zaidi STR; Van C; Thomson A; Castelino R
Expert Opin Drug Saf; 2021 Oct; 20(10):1267-1274. PubMed ID: 34077311
[No Abstract] [Full Text] [Related]
13. Are consumers ready to take part in the Pharmacovigilance System?--a Portuguese preliminary study concerning ADR reporting.
Matos C; van Hunsel F; Joaquim J
Eur J Clin Pharmacol; 2015 Jul; 71(7):883-90. PubMed ID: 26004569
[TBL] [Abstract][Full Text] [Related]
14. Awareness, knowledge, attitude and practice of adverse drug reaction reporting among health workers and patients in selected primary healthcare centres in Ibadan, southwestern Nigeria.
Adisa R; Omitogun TI
BMC Health Serv Res; 2019 Dec; 19(1):926. PubMed ID: 31796034
[TBL] [Abstract][Full Text] [Related]
15. Adverse Drug Reactions Reported by Healthcare Professionals: Reaction Characteristics and Time to Reporting.
Aung AK; Tang MJ; Adler NR; de Menezes SL; Goh MSY; Tee HW; Trubiano JA; Puy R; Zubrinich CM; Graudins LV
J Clin Pharmacol; 2018 Oct; 58(10):1332-1339. PubMed ID: 29733431
[TBL] [Abstract][Full Text] [Related]
16. Patient versus healthcare professional spontaneous adverse drug reaction reporting: a systematic review.
Inch J; Watson MC; Anakwe-Umeh S
Drug Saf; 2012 Oct; 35(10):807-18. PubMed ID: 22928729
[TBL] [Abstract][Full Text] [Related]
17. Community Pharmacists' Views and Experiences with ADR Reporting for Complementary Medicines: A Qualitative Study in New Zealand.
Barnes J; Butler R
Drug Saf; 2020 Nov; 43(11):1157-1170. PubMed ID: 32975740
[TBL] [Abstract][Full Text] [Related]
18. An investigation of pharmacovigilance and reporting of adverse drug reactions in hospitals: a cross-sectional study in China.
Zhao Z; Shen J; Shen C; Zhu B; Sun J; Yu J; Sun F; Song H
Curr Med Res Opin; 2021 Nov; 37(11):2001-2006. PubMed ID: 34376068
[TBL] [Abstract][Full Text] [Related]
19. Knowledge, Practice and Attitudes Toward Pharmacovigilance and Adverse Drug Reactions Reporting Process Among Health Care Providers in Dammam, Saudi Arabia.
Ali MD; Hassan YA; Ahmad A; Alaqel O; Al-Harbi H; Al-Suhaimi NM
Curr Drug Saf; 2018; 13(1):21-25. PubMed ID: 29256354
[TBL] [Abstract][Full Text] [Related]
20. Knowledge of Adverse Drug Reaction Reporting Among Healthcare Professionals in Bhutan: A Cross-Sectional Survey.
Dorji C; Tragulpiankit P; Riewpaiboon A; Tobgay T
Drug Saf; 2016 Dec; 39(12):1239-1250. PubMed ID: 27743333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
